These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26945262)

  • 1. 'Sailing in troubled waters': a review of the use of anticoagulation in adult cancer patients with thrombocytopenia.
    Ibrahim RB; Skewes MD; Kuriakose P
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):615-30. PubMed ID: 26945262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation Therapy in Patients with Chronic Kidney Disease.
    Saheb Sharif-Askari F; Syed Sulaiman SA; Saheb Sharif-Askari N
    Adv Exp Med Biol; 2017; 906():101-114. PubMed ID: 27628006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonheparin anticoagulants for heparin-induced thrombocytopenia.
    Kelton JG; Arnold DM; Bates SM
    N Engl J Med; 2013 Feb; 368(8):737-44. PubMed ID: 23425166
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.
    Napolitano M; Saccullo G; Marietta M; Carpenedo M; Castaman G; Cerchiara E; Chistolini A; Contino L; De Stefano V; Falanga A; Federici AB; Rossi E; Santoro R; Siragusa S; ; ; De Stefano V; Falanga A; Tosetto A; Avvisati G; Carpenedo M; Federici AB; Marietta M; Napolitano M; Rossi E; Santoro C; Castaman G; Cerchiara E; Chistolini A; Contino L; Mazzucconi MG; Nichele I; Russo L; Santi R; Santoro RC; Siragusa S; Tagariello G
    Blood Transfus; 2019 May; 17(3):171-180. PubMed ID: 30418130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
    Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
    J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.
    Ibrahim RB; Peres E; Dansey R; Abidi MH; Abella EM; Gumma MM; Milan N; Smith DW; Heilbrun LK; Klein J
    Bone Marrow Transplant; 2005 Jun; 35(11):1071-7. PubMed ID: 15821771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography.
    Chung J; Stevic I; Gantioqui J; Atkinson H; Chan AKC; Chan HHW
    Blood Coagul Fibrinolysis; 2021 Jul; 32(5):305-311. PubMed ID: 34231501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K antagonists in anticoagulant therapy of patients with cancer.
    Pasierski T
    Pol Arch Med Wewn; 2012; 122(1-2):60-4. PubMed ID: 22353708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
    Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
    Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
    Campbell PM; Ippoliti C; Parmar S
    J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.
    Houghton DE; Key NS; Zakai NA; Laux JP; Shea TC; Moll S
    Leuk Lymphoma; 2017 Nov; 58(11):2573-2581. PubMed ID: 28393576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study.
    Mantha S; Miao Y; Wills J; Parameswaran R; Soff GA
    J Thromb Thrombolysis; 2017 May; 43(4):514-518. PubMed ID: 28205078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversal for heparins and new anticoagulant treatments].
    Kortchinsky T; Vigué B; Samama CM
    Ann Fr Anesth Reanim; 2013 Jan; 32(1):37-49. PubMed ID: 23273505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
    Lassila R; Antovic JP; Armstrong E; Baghaei F; Dalsgaard-Nielsen J; Hillarp A; Holme PA; Holmström M; Johnsson H; Joutsi-Korhonen L; Sandset PM
    Semin Thromb Hemost; 2011 Apr; 37(3):328-36. PubMed ID: 21455867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.